We noticed a plateau in sales with the competition making an impact due to a new offering.
With some information gathered about the account we were able to form a plan for that account, pulling on a cross-functional team to remove the blocks we’d identified and make changes for that specific regional account. As a result of implementing the account plan, the sales curve changed, we returned to growth, increased F2F access with key customers and for the first time ever, this account allowed a visiting KOL to speak at a departmental meeting, something no other pharma company has achieved.
Business Unit Director, Global Pharmaceuticals Company